daunorubicin has been researched along with latrunculin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, D; Roufogalis, BD | 1 |
1 other study(ies) available for daunorubicin and latrunculin b
Article | Year |
---|---|
Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
Topics: Actins; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Colchicine; Cycloheximide; Cytochalasin D; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endosomes; Green Fluorescent Proteins; Humans; Lysosomes; Microtubules; Protein Synthesis Inhibitors; Protein Transport; Recombinant Fusion Proteins; Thiazolidines | 2007 |